Clinical Trials Browser

Stomach Neoplasms × Injections × 90 days × Clear all

NCT07110571 2026-01-09

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms